Efficacy of Gushen Dingchuan Pills and Western Medicine in Treating Stable Chronic Obstructive Pulmonary Disease Patients with Syndrome of Lung and Kidney Qi Deficiency

Kun GUI; Jun YANG; Qi-zhong LONG; Yu HUANG

doi:10.13422/j.cnki.syfjx.20190731

您当前的位置：

首页 >

文章列表页 >

Efficacy of Gushen Dingchuan Pills and Western Medicine in Treating Stable Chronic Obstructive Pulmonary Disease Patients with Syndrome of Lung and Kidney Qi Deficiency

Clinic | 更新时间：2021-02-09

- Efficacy of Gushen Dingchuan Pills and Western Medicine in Treating Stable Chronic Obstructive Pulmonary Disease Patients with Syndrome of Lung and Kidney Qi Deficiency
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 8, Pages: 89-94(2019)
- 作者机构：
  
  贵州医科大学　附属医院，贵阳　 550004
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20190731
  CLC： R25;R256;R256.1;R256.11
- Received：17 August 2018，
  
  Published Online：06 December 2018，
  
  Published：20 April 2019
- 稿件说明：
移动端阅览
Kun GUI, Jun YANG, Qi-zhong LONG, et al. Efficacy of Gushen Dingchuan Pills and Western Medicine in Treating Stable Chronic Obstructive Pulmonary Disease Patients with Syndrome of Lung and Kidney Qi Deficiency[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 89-94.
DOI：

Kun GUI, Jun YANG, Qi-zhong LONG, et al. Efficacy of Gushen Dingchuan Pills and Western Medicine in Treating Stable Chronic Obstructive Pulmonary Disease Patients with Syndrome of Lung and Kidney Qi Deficiency[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 89-94. DOI： 10.13422/j.cnki.syfjx.20190731.

摘要

目的：

固肾定喘丸对稳定期肺肾气虚证慢性阻塞性肺疾病(COPD)的康复效果及对血清中S100钙结合蛋白A8/A9复合物(S100A8/A9)，核转录因子(NF)-

B，肿瘤坏死因子(TNF)-

，白细胞介素(IL)-8和IL-1

水平变化的影响。

方法：

选择110例COPD稳定期患者作为研究对象，参照数字表法随机分为对照组和治疗组各55例。对照组参照《慢性阻塞性肺疾病诊治指南(2013年修订版)》予常规治疗。治疗组在对照组治疗的基础上口服固肾定喘丸，1.5～2.0 g/次，3次/d。两组疗程均为连续治疗12周。比较两组患者肺功能、肺肾气虚证症状评分、生活质量圣乔治呼吸问卷(SGRQ)评分及临床疗效；检测两组血清S100A8/A9

NF-

TNF-

IL-8

IL-1

水平。

结果：

治疗后，治疗组患者第1秒用力肺活量占预计值百分比(FEV

%)和第1秒钟用力肺活量占用力肺活量的比值(FEV

/FVC)水平均显著高于对照组，肺肾气虚证评分明显低于对照组(

0.01)。治疗组患者的临床疗效总有效率96.15%，高于对照组总有效率80.39%(

=4.777，

0.05)；治疗组患者SGRQ量表评分均低于对照组(

0.01)；治疗组患者S100A8/A9和NF-

B水平均明显低于对照组(

0.01)；治疗组治疗后血清TNF-

，IL-8，IL-1

水平均明显低于对照组(

0.01)。

结论：

固肾定喘丸联合西医常规康复措施治疗稳定期肺肾气虚证COPD，可改善患者的肺功能、肺肾气虚证评分、生活质量，提高临床疗效，且可降低血中S100A8/A9和NF-

B等炎症因子水平。

Abstract

Objective:

To observe the efficacy of Gushen Dingchuan pills combined with routine western medicine in treating stable chronic obstructive pulmonary disease (COPD) patients with syndrome of lung and kidney Qi yin deficiency

and investigate its effect on serum levels of S100 calcium binding protein A8/A9 complex (S100A8/A9)

nuclear factor (NF)-

tumor necrosis factor (TNF)-

interleukin (IL)-8 and IL-1

Method:

One hundred and ten stable chronic COPD patients were selected and randomly divided into control group (55 cases) and treatment group (55 cases) by the random number table. Cases of control group received routine therapy by reference to the

Guidelines for Diagnosis and Treatment for Chronic Obstructive Pulmonary Disease

(2013

Revision

). In addition to the therapy of control group

cases of treatment group were orally given Gushen Dingchuan pills(1.5-2.0 g/time

tid

). Both groups were treated for 12 weeks. Lung function

scores of symptoms of lung and kidney Qi Yin deficiency

life quality St. George's respiratory questionnaire (SGRQ) score

and the efficacy were compared between both groups. Serum levels of S100A8/A9

NF-

TNF-

IL-8 and IL-1

were detected for two groups.

Result:

After treatment

FEV

% and FEV

/FVC of treatment group were obviously higher

while score of symptoms of lung and kidney Qi deficiency were lower than control group (

0.01). Total efficacy rate of observation group was 96.15%

which was evidently higher than 80.39%of control group (

=4.777

0.05). After treatment

score of SGRQ scale was lower than control group (

0.01). Serum levels of S100A8/A9 and NF-

B of treatment group were obviously lower than those of control group (

0.01). Serum levels of TNF-

IL-8

IL-1

of treatment group were remarkably lower than control group after treatment (

0.01).

Conclusion:

Gushen Dingchuan pills combined with western medicine can treat stable chronic COPD patients with syndrome of lung and kidney Qi Yin deficiency by improving lung function

alleviating symptoms of lung and kidney Qi deficiency

increasing life quality and efficacy and decreasing levels of S100A8/A9 and NF-

B inflammatory factors.

关键词

Keywords

references

王梅，廖浩，裴文迪，等．长期无创正压通气治疗重度稳定期慢性阻塞性肺疾病合并呼吸衰竭的效果评价：一项随机对照试验的 Meta分析 [J]. 中国呼吸与危重监护杂志， 2018 , 17 ( 3 ): 223 - 229 .

白淑荣，吴源，王艳，等．百令胶囊联合补肺活血胶囊对肺肾气虚证慢性阻塞性肺疾病稳定期患者肺康复的影响 [J]. 中国实验方剂学杂志， 2016 , 22 ( 34 ): 182 - 186 .

瞿波，董守金，蔡林丽，等 . 慢性阻塞性肺疾病稳定期的中西医肺康复研究进展 [J]. 华西医学， 2014 ( 2 ): 385 - 390 .

李建生，余学庆，王明航，等 . 中医治疗慢性阻塞性肺疾病研究的策略与实践 [J]. 中华中医药杂志， 2012 , 27 ( 6 ): 1607 - 1614 .

杨勋，胡红玲，赵苏，等．固肾定喘丸对慢性阻塞性肺疾病患者稳定期肺功能及生活质量的影响 [J]. 中国实验方剂学杂志， 2013 , 19 ( 22 ): 283 - 286 .

赵四林，王伟 . 加味二仙丸对支气管哮喘临床缓解期患者血清白细胞介素及干扰素- γ 的影响 [J]. 中国中医药信息杂志， 2013 , 20 ( 4 ): 16 - 17 .

马蕴蕾，宿英豪，于向艳 . 固肾定喘丸对肺肾气虚型支气管哮喘慢性持续期患者血清ECP, NO, IL-6水平和肺功能的影响 [J]. 中药药理与临床， 2018 , 34 ( 1 ): 161 - 164 .

Halayko A J , Ghavami S. S100A8/A9：A mediator of severe asthma pathogenesis and morbidity？ [J]. Can J Physiol Pharmacol , 2009 , 87 ( 10 ): 743 - 755 .

中华医学会呼吸病学分会慢性阻塞性肺疾病学组．慢性阻塞性肺疾病诊治指南(2013年修订版) [J]. 中华结核和呼吸杂志， 2013 , 36 ( 4 ): 255 - 264 .

中华中医药学会内科分会肺系病专业委员会．慢性阻塞性肺疾病中医证候诊断标准(2011版) [J]. 中医杂志， 2012 , 53 ( 1 ): 80 - 84 .

徐鸥，郝青林，李锐洁，等．圣乔治呼吸问卷对慢性阻塞性肺疾病患者生活质量差异的调查 [J]. 昆明医学院学报， 2008 ( 2 ): 71 - 75 .

杨昆．调补肺肾法治疗慢性阻塞性肺病病因病机探析 [J]. 亚太传统医药， 2016 , 12 ( 11 ): 64 - 65 .

毛毳．平喘固本膏治疗慢性阻塞性肺疾病稳定期患者临床研究 [J]. 辽宁中医药大学学报， 2016 , 18 ( 6 ): 170 - 173 .

Reséndiz-Hernández J M , Falfán-Valencia R. Genetic polymorphisms and their involvement in the regulation of the inflammatory response in asthma and COPD [J]. Adv Clin Exp Med , 2018 , 27 ( 1 ): 125 - 133 .

KANG J H , HUANG S M , CHUANG I Y. S100A8，S100A9 and S100A12 activate airway epithelial cells to produce MUC5 AC via extracellular signal-regulated kinase and nuclear factor- κ B pathways [J]. Immunol , 2015 , 144 ( 1 ): 79 - 90 .

陈小菊，向小均，张文波，等．慢性阻塞性肺疾病稳定期和急性加重期血浆和诱导痰中S100A8/A9变化及其意义 [J]. 中国呼吸与危重监护杂志， 2017 , 16 ( 5 ): 509 - 512 .

Uluçkan Ö , Guinea-Viniegra J , Jimenez M , et al . Signalling in inflammatory skin disease by AP-1(Fos/Jun) [J]. Clin Exp Rheumatol , 2015 , 33 ( 4 Suppl 92 ): S44 - S49 .

Khazdair M R , Boskabady M H , Ghorani V. Respiratory effects of sulfur mustard exposure, similarities and differences with asthma and COPD [J]. Inhal Toxicol , 2015 , 27 ( 14 ): 731 - 744 .

Caramori G , Adcock I M , Di Stefano A , et al . Cytokine inhibition in the treatment of COPD [J]. Int J Chron Obstruct Pulmon Dis , 2014 , 28 ( 9 ): 397 - 412 .

Riva M , Källberg E , Björk P , et al . Induction of nuclear factor- κ B responses by the S100A9 protein is Toll-like receptor-4-dependent [J]. Immunol , 2012 , 137 ( 2 ): 172 - 182 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Dingkundan in Treatment of Qi Stagnation and Blood Stasis Syndrome in Patients with Chronic Obstructive Pulmonary Disease at Stable Phase

Effect of Dialectical Therapy of Bufeitang Combined with Shengesan and Fujiu Application on COPD at Stable Period and Lung-kidney Qi Deficiency Syndrome

Comprehensive Optimization of Rehabilitation Measures of Traditional Chinese Medicine to Elderly Patients with COPD at Stable Period

Effects of Lung Function of Shenqi Bufei Tang on Stable COPD Patient with Lung-Qi Deficiency Syndrome

Related Author

LI Guangxi

YAO Xiaoyan

XIA Kun

MA Jiang

YANG Zhaoquan

LIU Yanyi

Lan ZHOU

Shi-qing YAO

Related Institution

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Shanghai Fengxian District Traditional Chinese Medicine Hospital

Beijing Xicheng District Guangwai Hospital

The First Affiliated Hospital of Bengbu Medical College

Haikou Traditional Chinese Medicine Hospital

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰